This article is being processed. Please check back shortly.
Share this article
Analysis
Neutral
GSK gets China approval for Exdensur in nasal polyps, expanding respiratory portfolio
Apr 08, 2026 09:12 UTC
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.